For most people Adhesive Capsulitis (known more commonly as 'frozen shoulder') is a self-limiting condition of approximately one to three years duration. It happens when the flexible tissue surrounding the shoulder joint (capsule) becomes inflamed and thickened, resulting in contraction (tightening) of the tissue and scarring. The shoulder then becomes very tight, painful and stiff which often can be extremely debilitating and interfere with people’s work, home and leisure activities.
Most people eventually get better, even without treatment. However, for around one in 10 patients the condition is more resistant and these patients are referred to hospital. Hospital treatment commonly involves the following interventions:
There is limited evidence, however, on the clinical effectiveness of these treatments for the frozen shoulder.
Our research is a randomised controlled trial that will evaluate the clinical and cost-effectiveness of these three interventions. In addition, patient experiences of both the surgical interventions and ESP will be examined, providing important patient-centred insight to further guide clinical decision making.
If you would like to find out more about this study please contact:
Trial Manager: Dr Stephen Brealey (stephen.brealey@york.ac.uk).
Chief Investigator: Professor Amar Rangan (amar.rangan@york.ac.uk).